Large panels of human cancer cell lines, profiled at the DNA, RNA and chromosomal levels and tested for sensitivity to approved and potential drugs, will accelerate the search for new cancer therapies. See Article p.570 & Letter p.603
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Barretina, J. et al. Nature 483, 603–607 (2012).
Garnett, M. J. et al. Nature 483, 570–575 (2012).
Weinstein, J. N. Curr. Opin. Pharmacol. 2, 361–365 (2002).
Shoemaker, R. H. et al. Prog. Clin. Biol. Res. 276, 265–286 (1988).
Weinstein, J. N. et al. Science 275, 343–349 (1997).
Neve, R. M. et al. Cancer Cell 10, 515–527 (2006).
Sos, M. L. et al. J. Clin. Invest. 119, 1727–1740 (2009).
Greshock, J. et al. Cancer Res. 70, 3677–3686 (2010).
Lamb, J. et al. Science 313, 1929–1935 (2006).
The Cancer Genome Atlas Research Network Nature 455, 1061–1068 (2008).
The Cancer Genome Atlas Research Network Nature 474, 609–615 (2011).
The International Cancer Genome Consortium Nature 464, 993–998 (2010).
Box, G. E. P. in Robustness in Statistics: Proceedings of a Workshop (eds Launer, R. L. & Wilkinson, G. N.) (Academic, 1979).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Weinstein, J. Cell lines battle cancer. Nature 483, 544–545 (2012). https://doi.org/10.1038/483544a
Published:
Issue Date:
DOI: https://doi.org/10.1038/483544a